On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
Symptom Checklist Helps Primary Care Clinicians Assess SUD SeverityMay 30th 2023
The results show 26.3% of patients in the daily cannabis use only group endorsed 2 or more items on the symptom checklist, consistent with DSM-5 SUD, compared to 30.2% of the other drug use group and 51.8% of the daily cannabis and other drug use group.
After COVID-19, Psoriasis Patients Prefer Biologics with Infrequent Administration, Fewer Medical VisitsMay 30th 2023
This research from Japan on the shifting preferences for individuals with psoriasis in the pre and post-pandemic era may indicate the effects of such events on treatment options.
Hollis O'Neal, MD: Late Breaking Data on Diagnostic Test for Sepsis IntelliSepMay 29th 2023
Late-breaking data from ATS 2023 show new positive evidence of the innovative in-vitro diagnostic tool IntelliSep test that measures the viscoelastic properties of leukocytes, showing promising results for rapid sepsis diagnosis in EDs.
Victor Kim, MD: Addressing Comorbidities and Advancing COPD CareMay 28th 2023
Data indicates that addressing mood disorders in patients not only improves mood symptoms but also demonstrates positive effects on certain cardiac events, suggesting benefits for both mental and physical well-being.
Investigators Identify Risk Factors for HBV, HCV Among Pregnant WomenMay 27th 2023
There were several risk factors identified, including abortion, hospitalization, past surgical procedure, dental extraction, delivery in hospital, injection in hospitals, and household contact with jaundice.
Exploring the Impact of the Sotagliflozin Approval, with Deepak Bhatt, MD, MPHMay 27th 2023
Ahead of the sotagliflozin approval, Deepak Bhatt, MD, MPH, offers perspective into potential future research opportunities for the SGLT1/2 inhibitor and discusses the impact of a 3rd agent boasting SGLT2 inhibition receiving approval for heart failure.
Electronic Tool Developed to Help Clinicians Detect Antibiotic Allergic-Type ReactionsMay 27th 2023
New research has led to the development of an algorithm designed to help improve detection of allergic reactions to antibiotics, given that antibiotics are among the most common medication adverse event causes.
Diabetes Dialogue: What to Know about the iLet Bionic PancreasMay 26th 2023
As a follow-up to an episode earlier this year and the FDA clearances of the technology that forms the iLet Bionic Pancreas, hosts sat down in the MJH Life Sciences studio for a special edition recording to explore the implications of the clearance, dispel misconceptions surrounding the system, and hypothesize about the future of this technology in people with diabetes.
Global Prevalence of Psoriasis, MS, Other Autoimmune Diseases Higher in America, EuropeMay 26th 2023
Research into global prevalence rates of autoimmune conditions such as multiple sclerosis and psoriasis highlights important information for future research and medical resource allocation.
Diversity and Composition of Gut Microbiota Vary Between Healthy Individuals and HBV PatientsMay 26th 2023
A beta diversity analyses revealed a distinct clustering pattern between healthy controls and patients with HBV-related liver disease and the composition of bacteria from the phylum level to the genus level varies across the stages of liver disease.
Underreporting of Fall Injuries, Pressure Ulcers Associated with Racial, Ethnic Composition of Nursing HomesMay 26th 2023
These findings suggest that disparities in reporting data may be present in nursing homes, with implications for surveillance of nursing homes, priority setting for facilities, as well as payment and research.
The Prospect of SGLT1/2i in Heart Failure: Cardiologists Await FDA Decision on SotagliflozinMay 26th 2023
Ahead of the May 27, 2023 PDUFA date, the HCPLive Cardiology editorial team spoke to a group of cardiologists to capture their perspective of the potential role of sotagliflozin.